How Much Can In-Vitro Diagnostic Substance Manufacturing Businesses Get in SBA Loans?
25 SBA loans totaling $10.2M have been approved for in-vitro diagnostic substance manufacturing businesses (NAICS 325413). The average approved SBA loan is $408K, which is 20% above avg the $340K national average. 20 active lenders fund this industry.
NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing) received 25 SBA loans worth $10.2M across 5+ states. Average loan $408K, average term 128 months.20 active SBA-approved lenders fund this industry. Manufacturers (NAICS 31-33) qualify for FY2026 SBA fee waivers and the new MARC revolving credit program.
Is SBA Lending Growing for In-Vitro Diagnostic Substance Manufacturing?
FY2026 Manufacturing Fee Waivers Active
The SBA has waived guaranty fees for manufacturers (NAICS 31-33) through September 30, 2026:
504 loans — all guaranty fees waived for manufacturing
7(a) loans up to $950K — guaranty fee waived
Revolving credit line — manufacturers only (new Oct 2025)
The proposed Made in America Manufacturing Finance Act (H.R. 3174) would double SBA limits to $10M for domestic manufacturers — currently passed House, awaiting Senate vote.
Which SBA Program Do In-Vitro Diagnostic Substance Manufacturing Businesses Use Most?
What Is the Best SBA Loan for In-Vitro Diagnostic Substance Manufacturing?
Most popular for manufacturing equipment and real estate — with 0% guaranty fees in FY2026
Where Are In-Vitro Diagnostic Substance Manufacturing SBA Loans Most Common?
Top SBA Lenders for In-Vitro Diagnostic Substance Manufacturing
These banks have funded the most SBA loans for in-vitro diagnostic substance manufacturing businesses (NAICS 325413). PeerSense routes deals to lenders with proven appetite in your industry.
| # | Lender | Loans | Volume |
|---|---|---|---|
| 1 | CDC Small Business Finance Cor(CA) | 3 | $1.5M |
| 2 | Bank of America, National Association(NC) | 2 | $360K |
| 3 | Simmons Bank(AR) | 2 | $1.5M |
| 4 | KeyBank National Association(OH) | 2 | $900K |
| 5 | Bath Savings Institution(ME) | 1 | $700K |
In-Vitro Diagnostic Substance Manufacturing Industry Context
Ready to Fund Your In-Vitro Diagnostic Substance Manufacturing Business?
PeerSense places SBA loans for in-vitro diagnostic substance manufacturing businesses nationwide. We match you with the right capital source — no retainers, referral fee at closing.
Retainers
Down with SBA 7(a)
Terms Available
Financing a In-Vitro Diagnostic Substance Manufacturing business? Get matched to an SBA lender.
Tell us your loan amount and use of funds. We route you to the lender most likely to fund a deal in your industry.
SBA 7(a) / 504 — Response within 4 business hours. No obligation.
How Does SBA Lending Work for In-Vitro Diagnostic Substance Manufacturing Businesses?
Across all SBA loan programs, 25 loans have been approved for businesses classified under NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), representing $10.2M in total capital deployed. The average approved loan of $408K is 20% above avg the national SBA average of $340K, with typical repayment terms of 128 months.
SBA lending for in-vitro diagnostic substance manufacturing has remained relatively stable across recent fiscal years. 20 active lenders continue funding this sector, providing consistent access to capital for both new ventures and established businesses looking to expand.
Notably, 24% of SBA loans in this industry use the 504 program — well above the national average — indicating that in-vitro diagnostic substance manufacturing businesses frequently finance major fixed assets like real estate, heavy equipment, or facility buildouts. The 504 program offers up to $5.5M with below-market fixed rates and only 10% down from the borrower.
As a manufacturing business under NAICS 31-33, you qualify for enhanced SBA incentives through September 30, 2026. The SBA has fully waived guaranty fees on all 504 loans and on 7(a) loans up to $950,000 for manufacturers. Additionally, the MARC (Manufacturers' Access to Revolving Credit) program launched in October 2025, offering up to $5M in revolving credit exclusively for domestic manufacturers — a first for SBA lending.
Frequently Asked Questions — In-Vitro Diagnostic Substance Manufacturing SBA Loans
What is the average SBA loan size for in-vitro diagnostic substance manufacturing businesses?
Which SBA loan program is best for a in-vitro diagnostic substance manufacturing business?
How many lenders fund SBA loans for in-vitro diagnostic substance manufacturing?
Are there SBA fee waivers for manufacturing businesses in 2026?
How does PeerSense help in-vitro diagnostic substance manufacturing businesses get SBA loans?
Related Manufacturing Industries
Commercial Gravure Printing
Commercial Lithographic Printing
Commercial Screen Printing
All Other Plastics Product Manufacturing
Other Commercial Printing
Cut Stone and Stone Product Manufacturing
Data aggregated from SBA loan records (1992–2025). In-Vitro Diagnostic Substance Manufacturing defined by NAICS code 325413. Not financial advice. PeerSense is a capital advisory firm, not a lender. Consult a lending professional before making financial decisions.